Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2022-05-24 00:00:00 ET · period of report 2022-05-20 · accession 0001439222-22-000051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-24 | 2022-05-20 | AGIO | Schenkein David P | Dir | M - OptEx | $0.00 | +1,585 | 117.9K | +1% | $0 |
| D | 2022-05-24 | 2022-05-20 | AGIO | Schenkein David P | Dir | M - OptEx | $0.00 | -1,585 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2022-05-20 | M | A | 1,585 | $0.00 | 117,879 | D | — | — | |
| 2 | Derivative | Restricted stock unit | 2022-05-20 | M | D | 1,585 | $0.00 | 0 | D | — · — to — | 1,585 Common stock | (F3) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. (F4) There restricted stock units were granted on May 20, 2021. The shares underlying these restricted stock units vest as to 100% of the underlying shares on May 20, 2022. |